An article published in the journal eLife reports a study in which researchers concluded that the proportion of the population previously infected with SARS-CoV-2 (infection-induced seroprevalence) can be estimated using donated blood samples. The findings offer a kind of “portrait” of the first year of the COVID-19 epidemic in Brazil. Their new methodology could also be used to track and evaluate herd immunity to other infectious diseases, the authors say.
The usual method for estimating seroprevalence in Brazil is based on random samples of the population. The authors note that this method is expensive and difficult to perform periodically in real time. Serological surveillance is important for understanding the characteristics of epidemics and for formulating public policy, for example by identifying areas where prevention and treatment are effective.
The main authors are affiliated with the Brazilian-British Center for the Detection, Diagnosis, Genomics and Epidemiology of Arboviruses (CADDE). They tested 97,950 donated blood samples for antibodies to immunoglobin G (IgG). Samples were collected in the eight most populous Brazilian state capitals: Belo Horizonte, Curitiba, Fortaleza, Manaus, Recife, Rio de Janeiro, Salvador and São Paulo. The study period lasted from March 2020 to March 2021.
The results showed that the COVID-19 epidemic is spreading unevenly, affecting the population of these cities at different times. Seroprevalence tended to be highest among men and young adults.
“Previously, some lines of investigation suggested that everyone was infected at the same time, but we have shown that this is not the case. In terms of the epidemic profile, we concluded that it was highly heterogeneous in Brazil, with varying infection rates between groups and significant differences in fatality rates. We did not expect such a result,” Carlos Augusto Prete Jr., the first author of the paper, told Agência FAPESP.
Prete Junior is a Research Fellow at the School of Engineering at the University of São Paulo (POLI-USP). This research was part of his doctoral dissertation. His supervisors are Vitor Elois Nascimento, POLI-USP Professor, and Esther Sabino, University Medical School (FM-USP) Professor and CADDE Principal Investigator. Nascimento and Sabino are the final authors of the paper.
The research was supported by FAPESP through CADDE and a scholarship awarded by Prete Junior. It also received funding from the Instituto Todos pela Saúde (“Everything for Health”, an initiative led by Itaú, Brazil’s largest private bank). The other authors are scientists from Imperial College London and the University of Oxford in the United Kingdom.
In another recent paper published in Vaccines, the team analyzed donated blood samples to show that their method could be used to predict the arrival of the SARS-CoV-2 delta variant (first detected in India in 2020 and originally named B. 1.617) in Brazil. .2). They tested anti-spike protein microparticles to measure levels of IgG antibodies that bind to the S (spike) protein of the virus and prevent it from infecting cells. They found a relationship between the protection provided by the vaccine, the number of cases and the death rate from the delta variant (for more details, see agencia.FAPESP.br/39629).
Methodology
Brazil’s COVID-19 epidemic has been one of the worst in the world, with 35.4 million cases and 690,000 deaths by early December 2022. However, these figures do not reflect significant differences between regions and population subgroups or proportions previously infected with the novel coronavirus. Estimating this proportion is important in predicting the impact of future waves caused by new variants of the virus.
In the study, in addition to assessing the incidence or prevalence of the disease over time for eight cities using donated blood samples disaggregated by sex and age, the researchers also estimated the age-specific infection fatality rate (IFR) and infection hospitalization rate in each city.
The researchers tested 1,000 samples per city every month. To ensure that the samples are representative, they were selected so that the location of the donors’ houses corresponded to the spatial distribution of the population in the respective areas.
By law, donated blood is stored in Brazil for six months, so the researchers were able to collect and test samples frozen between February (before the start of the pandemic in Brazil) and July 2020. After this period, samples were taken and tested. currently.
IgG antibodies against the SARS-CoV-2 nucleocapsid (N) were detected using a chemiluminescent microparticle immunoassay, as it was the only automated kit commercially available in Brazil at the start of the study (July 2020). However, this type of test may lose sensitivity over time due to declining antibody levels, and the decline in the proportion of people who test positive may have increasingly underestimated the true rate of lesions as the epidemic progressed.
To correct for this loss of antibody detection due to a weakened immune system or a decrease in antibody concentration over time (seroreversion), the researchers developed a Bayesian model using data for repeat blood donors (people who donate blood several times a year) and cohorts. among non-hospitalized convalescent plasma donors with symptoms who tested positive for SARS-CoV-2 by PCR within 60 days of symptom onset.
“The inclusion of repeat donors was important because in some studies done early in the pandemic, seroreversion was corrected using plasma donors only. We have shown that repeat donors are more representative of the population in each city,” Prete Junior said.
He noted that this model did not appear in the same group’s article published in Science in December 2020, with information from the Manaus blood bank, as there was not enough data available at the time. In this study, led by Sabino, they calculated that 76% of the city’s population was immune to the virus, but that was before other variants, such as gamma, were later considered more aggressive and deadly (read more at agencia.FAPESP.br). /35011).
“Shortly after the publication of the article, the second wave of COVID-19 began in Brazil. At that time, many thought that there would be no re-infection. We have now confirmed that donated blood samples can be used to assess seroprevalence for monitoring other diseases, provided that certain adjustments are made, such as adjusting for seroreversion and estimating the frequency of lesions for each age and sex group using spatially representative samples. said Prete the Younger.
The results showed that the attack rate in December 2020, before the gamma variant became predominant, ranged from 19.3% in Curitiba to 75% in Manaus. Seroprevalence was consistently lower among women and donors over 55 years of age.
Cities with higher seroprevalence also had higher mortality rates (deaths per 1,000 inhabitants). Between March 1, 2020 and March 31, 2021, the age-standardized death rate ranged from 1.7 in Belo Horizonte to 5.3 in Manaus, where the death rate was twice that of Fortaleza, the city with the second highest mortality rate among those analyzed.
The infection fatality rate (IFR) also varied between cities, from 0.24% in Manaus to 0.54% in Curitiba, and the age-specific IFR increased steadily with age.
Investigators estimated IFR using the total number of deaths from severe acute respiratory infection (SARI), including PCR- and clinically confirmed SARS-CoV-2 infection, and deaths from SARI without a definitive diagnosis, and excluded deaths from SARI confirmed by other causes. illness. This approach corrected for the effect of underreporting, especially in 2020 when testing was not widely available.
Manaus
The gamma variant (P.1) was discovered in November 2020 and its prevalence increased rapidly, reaching 87% on January 4, 2021, with a high reinfection rate, and for this reason IGF and attack rate were estimated separately. for the second wave in Manaus, when gamma dominated.
The study found that the proportion of the population of Manaus infected in the second wave was 37.5% compared to 75% during the first wave. The infection hospitalization rate increased during the second wave in the city, indicating an increase in the severity of the disease caused by gamma radiation compared to previous options.
The increased penetration of COVID-19 and the inability of the Manaus healthcare system to cope with the influx of cases has led to gamma-related IFR reaching levels at least 2.91 times higher than in the first wave.
About the Sao Paulo Research Foundation (FAPESP)
The São Paulo Research Foundation (FAPESP) is a public institution whose mission is to support scientific research in all fields of knowledge by providing fellowships, fellowships and grants to researchers associated with higher education and research institutions in the state of São Paulo, Brazil. FAPESP is aware that the best research can only be done in collaboration with the best researchers at the international level. Therefore, he has established partnerships with funding agencies, higher education, private companies and research organizations in other countries known for the quality of their research, and encourages scientists funded by his grants to further develop their international collaborations. You can learn more about FAPESP at www.FAPESP.br/en and visit the FAPESP news agency at www.agencia.FAPESP.br/en to keep up to date with the latest scientific discoveries that FAPESP helps achieve through its many programs, awards and research centers. You can also subscribe to the FAPESP news agency at https://agencia.FAPESP.br/subscribe.
/Public version. This material from the original organization/author(s) may be of a point-in-time nature, edited for clarity, style and length. The views and opinions expressed are those of the author(s). View in full here.